Search research articles
Contact Us
Filters
Showing results (121-130 of 241) with videos related to
Page
of 25
Sort By:
Journal of Cachexia, Sarcopenia and Muscle
|
January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity
Pauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
The American Journal of Gastroenterology
|
August 26, 2010
Outcome of patients with type 1 or 2 autoimmune pancreatitis
Frédérique Maire, Yann Le Baleur, Vinciane Rebours, et al.
Gastroenterologie Clinique Et Biologique
|
January 14, 2005
Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
Thierry André, Monique Noirclerc, Pascal Hammel, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
Emmanuel Mitry, Pascal Hammel, Gaël Deplanque, et al.
United European Gastroenterology Journal
|
April 26, 2019
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score
Louis de Mestier, Marie Muller, Jérôme Cros, et al.
The American Journal of Gastroenterology
|
December 14, 2011
Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations
Caroline Bertin, Anne-Laure Pelletier, Marie Pierre Vullierme, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 2, 2011
Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions
Yann Le Baleur, Anne Couvelard, Marie Pierre Vullierme, et al.
Annals of Surgery
|
September 5, 2014
Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place
Louis de Mestier, Sébastien Gaujoux, Jérôme Cros, et al.
Cancer Treatment Reviews
|
June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence
Thomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 20, 2005
Is idiopathic chronic pancreatitis an autoimmune disease?
Karine Nahon Uzan, Philippe Lévy, Dermot O'Toole, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 241) with videos related to
Sort By:
Page
of 25
Journal of Cachexia, Sarcopenia and Muscle
|
January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity
Pauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
The American Journal of Gastroenterology
|
August 26, 2010
Outcome of patients with type 1 or 2 autoimmune pancreatitis
Frédérique Maire, Yann Le Baleur, Vinciane Rebours, et al.
Gastroenterologie Clinique Et Biologique
|
January 14, 2005
Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
Thierry André, Monique Noirclerc, Pascal Hammel, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2010
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
Emmanuel Mitry, Pascal Hammel, Gaël Deplanque, et al.
United European Gastroenterology Journal
|
April 26, 2019
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon score
Louis de Mestier, Marie Muller, Jérôme Cros, et al.
The American Journal of Gastroenterology
|
December 14, 2011
Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations
Caroline Bertin, Anne-Laure Pelletier, Marie Pierre Vullierme, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 2, 2011
Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions
Yann Le Baleur, Anne Couvelard, Marie Pierre Vullierme, et al.
Annals of Surgery
|
September 5, 2014
Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place
Louis de Mestier, Sébastien Gaujoux, Jérôme Cros, et al.
Cancer Treatment Reviews
|
June 5, 2019
Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence
Thomas Seufferlein, Pascal Hammel, Jean Robert Delpero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 20, 2005
Is idiopathic chronic pancreatitis an autoimmune disease?
Karine Nahon Uzan, Philippe Lévy, Dermot O'Toole, et al.
Page
of 25